首页> 外国专利> 2,4-DIAMINOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, THEIR USE FOR THE PREPARATION OF DOPAMINE D4 ANTAGONIST PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN LABELING DOPAMINE D4 RECEPTOR

2,4-DIAMINOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, THEIR USE FOR THE PREPARATION OF DOPAMINE D4 ANTAGONIST PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN LABELING DOPAMINE D4 RECEPTOR

机译:2,4-二氨基嘧啶衍生物,其制备方法,其用于制备多巴胺D4拮抗剂药物组合物的用途及其在标记多巴胺D4受体中的用途

摘要

PCT No. PCT/EP97/02506 Sec. 371 Date Nov. 9, 1998 Sec. 102(e) Date Nov. 9, 1998 PCT Filed May 2, 1997 PCT Pub. No. WO97/43279 PCT Pub. Date Nov. 20, 1997The present invention concerns the compounds of formula the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein Alk is C1-6alkanediyl or C3-6alkenediyl; R1 is hydrogen or C1-4alkyl; R2 and R3 each independently are hydrogen, C1-6alkyl or C3-7cycloalkyl; or R2 and R3 may also be taken together with the nitrogen atom to which they are attached, thus forming a pyrrolidine, a piperidine or a perhydro azepine ring; R4 is hydrogen or halo; Q is aryl, aryloxy, di(aryl)methyl or heteroaryl; aryl is naphthyl or phenyl, said naphthyl and phenyl may optionally be substituted; and heteroaryl is quinolinyl, isoquinolinyl, pyridinyl, thienyl, indolyl, 2,3-dihydro-1,4-benzodioxinyl, 2,3-dihydro-benzofuranyl or benzodioxolanyl; said heteroaryls may optionally be substituted: it further relates to processes for their preparation, compositions comprising them as well as their use as a medicine; compounds of formula (I) containing a radioactive isotope; a process of marking dopamine D4 receptor sites; and a process for imaging an organ are disclosed.
机译:PCT号PCT / EP97 / 02506 371日期,1998年11月9日,秒102(e),1998年11月9日,PCT,1997年5月2日提交,PCT Pub。 WO97 / 43279 PCT公开1997年11月20日,本发明涉及式N-氧化物形式的化合物,其药学上可接受的酸加成盐及其立体化学异构形式,其中Alk为C 1-6烷二基或C 3-6烯二基; R1是氢或C1-4烷基; R2和R3各自独立地是氢,C1-6烷基或C3-7环烷基;或者R2和R3也可以与它们所连接的氮原子一起被结合,从而形成吡咯烷,哌啶或全氢a庚环。 R4是氢或卤素; Q是芳基,芳氧基,二(芳基)甲基或杂芳基;芳基是萘基或苯基,所述萘基和苯基可任选被取代;杂芳基为喹啉基,异喹啉基,吡啶基,噻吩基,吲哚基,2,3-二氢-1,4-苯并二恶烯基,2,3-二氢-苯并呋喃基或苯并二氧戊环基。所述杂芳基可以任选地被取代:它进一步涉及它们的制备方法,包含它们的组合物以及它们作为药物的用途;含有放射性同位素的式(I)化合物;标记多巴胺D4受体位点的过程;公开了一种用于使器官成像的方法。

著录项

  • 公开/公告号IL126969A

    专利类型

  • 公开/公告日2003-01-12

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA N.V.;

    申请/专利号IL19970126969

  • 发明设计人

    申请日1997-05-02

  • 分类号C07D401/12;C07D401/14;C07D405/14;C07D409/14;A61K31/44;A61P25/00;

  • 国家 IL

  • 入库时间 2022-08-22 00:02:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号